Extracellular signal-regulated kinase 1/2 (ERK1/2) induces S272 phosphorylation and prolongs half-life of FOXC1 protein in cervical cancer [24], while SUMOylation of FOXC1 inhibits its transcriptional activity [25]. This evidence concerns the gene FOXC1 and cervical cancer.